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Extracellular vesicles (EV) are membrane-enclosed microstructures released from the cell. EV 
can transport cargo—such as DNA, RNA, and proteins—into the extracellular space and act as a 
form of intercellular communication. Matrix vesicles (MV) are a unique type of EV produced by 
mineralizing cells. In previous studies, utilizing in vitro models of pre-odontoblasts and vascular 
smooth muscle cells, it was determined that phosphate induces the release of MV and alters MV 
composition. We hypothesized that elevated phosphate alters the composition of MV through the 
alteration of gene expression. To determine whether this hypothesis holds true or not, 17IIA11 
cells, a pre-odontoblast cell line, were exposed to elevated phosphate for 24h, 48h, and 72h. 
RNA and MV were then collected for further analysis. Using nanoparticle tracking analysis, we 
determined that the size distribution of the MV was not altered by the phosphate. Next, to 
evaluate a possible mechanism driving MV composition change, we compared the effect of 
phosphate on gene expression to the effect of phosphate on MV composition. No correlation was 
identified between changes in gene expression and changes in MV composition. These findings 
suggest that phosphate does not alter the composition of MV through altered gene expression. 
Future studies should focus on other mechanisms that may drive MV composition changes. 
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1.0  INTRODUCTION 
1.1 EXTRACELLULAR VESICLES 
Extracellular vesicles (EV) are membrane-enclosed microstructures released from the cell. EV 
can transport cargo—such as DNA, RNA, and proteins—into the extracellular space and act as a 
form of intercellular communication. All cells release EV and, the cargo of EV often retains its 
biological function. There are several types of EV, characterized based on their biogenesis or 
release pathways; the most well-defined types of EV are apoptotic bodies, exosomes, 
microvesicles (Figure 1) (György, Szabó et al. 2011, Yuana, Sturk et al. 2013, Colombo, Raposo 
et al. 2014, Yanez-Mo, Siljander et al. 2015, Zaborowski, Balaj et al. 2015, Hasegawa 2018). 
Apoptotic bodies are released after the initiation of apoptotic cell death. This type of EV involves 
blebs directly from the plasma membrane with a diameter ranging in size from 500 nanometers 
(nm) to 1 micrometer (µm). Exosomes, another commonly studied EV subtype, are formed 
through the fusion of multivesicular bodies containing smaller vesicles and the plasma 
membrane, which results in the release of the smaller vesicles (exosomes) ranging in diameter 
from 40nm to 120nm. A third EV subtype, microvesicles, bud directly from the plasma 
membrane, contain cytoplasmic cargo, and range in diameter from 50nm to 1 µm (Roberts, 
Stewart et al. 2004, Thery, Amigorena et al. 2006, Julien, Khoshniat et al. 2009, György, Szabó 
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et al. 2011, Yuana, Sturk et al. 2013, Colombo, Raposo et al. 2014, Yanez-Mo, Siljander et al. 
2015, Zaborowski, Balaj et al. 2015, Bottini, Mebarek et al. 2018).  
Current research in the field suggests that the function of EV is related to the composition 
of the cargo. An early study by Théry et al. (2001) evaluating the composition of EV released 
from dendritic cells established the first extensive protein map of an EV population, showing that 
the composition of vesicles released by dendritic cells could impart an immunostimulating 
function (Théry, Boussac et al. 2001). This study suggests that EV act as a form of cell-cell 
communication. 
Other studies of EV have theorized that the roles of EV are far more varied than 
previously thought. For example, EVs have been found to contain and carry the receptors of 
many growth factors, such as TNF-α, EGF, and FGF. The extracellular matrix (ECM) retains 
these growth factors, and they can be released during ECM remodeling. The release of these 
molecules can regulate cell proliferation, migration, and morphogenesis. EV containing the 
receptors for these factors suggest that they may play a role in regulating their release. EVs have 
also been found to contain matrix metalloproteinases with proteolytic activity and EV may play a 
role in alteration of EV content and ECM degradation (Rackov, Garcia-Romero et al. 2018). 
These findings indicate the diverse roles EV can play in cellular function. 
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1.2 MATRIX VESICLES 
In bone biology, we find a fourth well-defined type of EV: matrix vesicles (MV). These range in 
size from approximately 80nm to 220nm and bud from specific regions of the plasma membrane. 
MV are a unique set of EV that anchor to the ECM and initiate the mineralization of the ECM 
through the nucleation of hydroxyapatite. They are known to be released from mineralizing cells 
such as hypertrophic chondrocytes and osteoblasts. Furthermore, EV derived from arterial 
endothelial cells, vascular smooth muscle cells, and macrophages have been associated with the 
pathological mineralization of the arteries, a dangerous complication of cardiovascular diseases.  
(Anderson 1967, Boyan, Schwartz et al. 1989, Wuthier and Lipscomb 2011, Shapiro, Landis et 
al. 2015, Chaudhary, Kuzynski et al. 2016, Bottini, Mebarek et al. 2018, Chaudhary, Khalid et al. 
2018, Hasegawa 2018).  
The composition of MV released from stem cells undergoing osteogenic differentiation 
(using an osteogenic medium composed of an inorganic phosphate (Pi) source and ascorbic acid) 
 
Figure 1. Extracellular vesicles (EV) are produced by cells and vary by type. 
Exosomes and microvesicles are produced from both healthy and diseased cells, whereas apoptotic bodies 
are produced by cells undergoing apoptosis. Adapted from Zaborowski et al. 2015 
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has been previously studied. These MV were shown to be enriched in the proteins involved in 
mineralization such as tissue non-specific alkaline phosphatase (TNAP), calcium phosphate 
transporters, and annexesins (calcium transporters). These vesicles are also enriched in ESCRT 
(endosomal sorting complexes required for transport) proteins, suggesting they are packaged and 
sorted through the endosomal pathway before being released into the ECM (Thouverey, 
Malinowska et al. 2011).  
Studies of cartilage and arteries have also identified MV as being associated with 
pathological mineralization. However, one study comparing the proteomes of MV released from 
normal and osteoarthritic cartilage found that only a small number of proteins, mostly involved 
in inflammation, were different between the two groups (Rosenthal, Gohr et al. 2011).  Another 
study evaluating MV from normal cartilage samples identified full-length mRNA contained in 
MV for collagen II, aggrecan, and ANKH, an inorganic pyrophosphate transport regulator. When 
chondrocytes were then exposed to these MV, the MV were internalized, and there was an 
observed change in gene expression by these genes (Mitton, Gohr et al. 2009).  
 While the composition of MV released from osteoblasts, chondrocytes, and cartilage has 
been evaluated, our group was the first to evaluate the composition of MV released from 
odontoblasts, which undergo physiologic mineralization, as well as vascular smooth muscle 
cells, which undergo pathologic mineralization. From these studies, we identified Pi as an 
initiator of MV release from these cells (Figure 2) (Anderson, Garimella et al. 2005, Yuana, 
Sturk et al. 2013, Chaudhary, Kuzynski et al. 2016, Chaudhary, Khalid et al. 2018).  
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1.3 PHOSPHATE AND MINERALIZATION 
Pi is one of the most important and abundant ions present in the body. It is part of the DNA 
backbone, stores energy in the form of ATP, and activates enzymes through phosphorylation. It  
is a major component of hydroxyapatite and, most importantly for our study, acts as a signaling 
molecule, particularly in the initiation of mineralization (2006, Khoshniat, Bourgine et al. 2011, 
Chaudhary, Kuzynski et al. 2016, Chaudhary, Khalid et al. 2018).  
Elevated Pi is provided, in part, to the cell locally through conversion of pyrophosphate to 
Pi by TNAP, and it signals for osteogenic differentiation of stem cells (Ciancaglini, Yadav et al. 
2010, Wuthier and Lipscomb 2011, Millan 2013, Huesa, Houston et al. 2015, Fakhry, 
Roszkowska et al. 2017). Unpublished data from our lab has indicated that Runt-related 
transcription factor 2 (Runx2), the master regulator of osteogenic differentiation, is up-regulated 
by elevated Pi in a pre-odontoblast cell line (data not shown), suggesting that Pi may regulate 
osteogenic differentiation through alteration of gene expression. Furthermore, a study utilizing 
MC3T3-E1 cells (a pre-osteoblastic cell line) showed significant modulation of protein 
expression, specifically in functions related to cell cycle regulation, proliferation, and DNA 
synthesis, when exposed to elevated Pi (Conrads, Yi et al. 2005).  
Several studies have also identified alteration of gene expression of proteins related to 
mineralization when osteogenic progenitor cells and osteosarcoma cells were exposed to 
elevated Pi. These proteins include osteopontin (OPN), and dentin matrix protein 1 (DMP1) 
(Beck, Zerler et al. 2000, Beck, Moran et al. 2003, R. 2003, Conrads, Yi et al. 2005, Khoshniat, 
Bourgine et al. 2011).  In an unpublished RNA-seq analysis of 17IIA11 cells (17A, a pre-
odontoblast cell line) exposed to elevated Pi, we identified significant alteration of gene 
expression of genes known to be involved in the mineralization of the ECM (data not shown). 
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This finding provides further evidence supporting Pi’s role as a signaling molecule involved in 
mineralization. 
However, very little is understood about the pathways through which Pi acts. The only 
known mediators of phosphate signaling include Extracellular signal-regulated kinase 1 and 2 
(ERK1/2). Members of the Pi transporter (PiT) family are the only known transporters of Pi into 
the cell. Of further interest to this study is the fact that many of the proteins known to regulate 
local concentrations of phosphate (TNAP, PiT-1) are known to be enriched in MV (Beck, Zerler 
et al. 2000, Beck, Moran et al. 2003, R. 2003, Conrads, Yi et al. 2005, Julien, Khoshniat et al. 
2009, Khoshniat, Bourgine et al. 2011, Wuthier and Lipscomb 2011, Bottini, Mebarek et al. 
2018). Another intriguing observation is that the protein products of genes affected by elevated 
Pi are known to reside in the ECM during mineralization and are important regulators of 
mineralization (DMP1 and OPN)  (McKee and Nanci 1996, Beck, Zerler et al. 2000, R. 2003, 
Khoshniat, Bourgine et al. 2011, Chaudhary, Khalid et al. 2018). As Pi acts as a signaling 
molecule, and many regulators of Pi and mineralization are enriched in MV, we decided to 
investigate whether Pi played a role in MV composition and release from osteogenic cells and 
found that it did (Figure 2). 
1.4 PHOSPHATE AND EXTRACELLULAR VESICLE RELEASE FROM 
OSTEOGENIC CELLS 
MV have long been thought to be the nucleation sites of hydroxyapatite crystals (Wuthier and 
Lipscomb 2011, Alves, Eijken et al. 2014, Chaudhary, Kuzynski et al. 2016, Bottini, Mebarek et 
al. 2018, Chaudhary, Khalid et al. 2018, Hasegawa 2018). In previous work, we evaluated the 
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role of Pi in the stimulation of MV release. Using the 17IIA11 (17A) cell line, we determined 
that Pi was responsible for the increased MV production (Figure 2A.). We also determined that 
the EV collected from the ECM possibly contained amorphous hydroxyapatite  suggesting they 
are mineralization competent (Chaudhary, Kuzynski et al. 2016). Furthermore, when we exposed 
a vascular smooth muscle cell line (MOVAS) to elevated Pi, we observed an increase in MV 
release after 72h(Figure 2B) (Chaudhary, Khalid et al. 2018). These two studies confirmed the 
importance of Pi for induction of mineralization and led to new questions about how these MV 
are produced, what their function may be, and how Pi alters them. 
Once we established that Pi induces MV release, we wanted to investigate whether the 
protein composition of the MV released from both 17A and MOVAS cells was altered due to Pi. 
We did this because it is thought that the composition of EV (of which MV is a subset) is 
thought to reflect their function. From our literature review, we also found that previous studies 
collected MV from both the medium and ECM of cultured cells for evaluation. However, we 
hypothesized that these vesicle populations would have different functional roles from each other 
and therefore varied compositions. As a result, we decided to evaluate them separately. Using 
mass spectrometric analysis, we determined that elevated Pi exposure alters the protein 
composition of EV from both the medium and ECM in 17A (unpublished, Figure 3A) and 
MOVAS  cells (Figure 3B) (Chaudhary, Khalid et al. 2018). 
From our previous findings, we hypothesized that elevated Pi alters the composition of 
MV through alteration of the gene expression of odontoblasts. 
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Figure 2. Phosphate induces extracellular vesicle release from mineralization-competent cells. 
A. Comparison of the number of MV released by cells within 24h of stimulation with standard osteogenic 
medium (ascorbic acid and Pi; AA + Pi), 10 mM Na-Pi buffer (Pi), or ascorbic acid (AA), with cells 
cultured in standard growth medium (Cntrl). Data are represented as the mean values of three independent 
experiments ± SD, *p<0.05 and **p<0.005. B. Results of nanoparticle tracking analyses show the number 
of EVs isolated from conditioned medium (medium) or extracellular matrix (ECM) of MOVAS cells grown 
in the presence of 10 mM Pi for 24, 48 and 72h. Data are represented as the mean values of three 
independent experiments ± SD, *p<0.01. Adapted from (Chaudhary, Kuzynski et al. 2016) 
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Figure 3 Phosphate alters protein composition of EV from 17A and MOVAS cells 
Summary of proteomic analyses of EVs released from MOVAS cells under standard growth conditions (Ctrl) 
and upon 24 h treatment with 10 mM Pi (Pi). EVs were isolated either from conditioned medium (medium) 
or from the extracellular matrix (ECM). A. Venn diagrams summarizing the effect of high Pi on EV protein 
composition of EV released from 17IIA11 (17A) cells B. Venn diagrams summarizing the effect of high Pi 
on EV protein composition released from MOVAS cells. Adapted from (Chaudhary, Khalid et al. 2018). 
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2.0  OBJECTIVE OF STUDY 
Matrix vesicle (MV) release is odontoblasts has been under-studied. Most studies evaluate MV 
in the context of later stages of chondrogenesis or osteogenesis and without identification of the 
factor that stimulates the release of these vesicles. In our previous study, we identified Pi as the 
driver of an early MV release from a pre-odontoblast cell line and vascular smooth muscle cell 
line. Furthermore, we determined that elevated Pi exposure alters both the vesicle composition 
and the gene expression of osteogenic cells. Considering these observations, the objective of this 
study is to determine if alteration of gene expression is a mechanism through which vesicle 
composition is altered. 
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3.0  MATERIALS AND METHODS  
3.1 CELL LINES 
The 17IIA11 (17A) is a mouse pre-odontoblast cell line generated by Priam et al (2005). 17A 
were maintained in Dulbecco's Modified Eagle Medium supplemented with 5% fetal bovine 
serum (FBS) and 100 units/ml penicillin and 100 ug/ml streptomycin. This cell line was 
maintained at 37ºC and at 5% carbon dioxide.  
The MOVAS cell line is a mouse aortic smooth muscle cell line obtained from the 
ATCC. It was maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 
10% FBS and 100 units/ml penicillin and 100 µg/ml streptomycin (Cellgro, Manassas, VA). This 
cell line was maintained at 37 ºC and at 5% carbon dioxide. 
3.2 EXPERIMENTAL DESIGN 
3.2.1 Exome-Depleted Fetal Bovine Serum Preparation 
FBS was diluted to a concentration of 20% with DMEM supplemented with 100 units/ml 
penicillin and 100 µg/ml streptomycin (Cellgro, Manassas, VA). The FBS solution was 
centrifuged at 100,000 rpm in an ultracentrifuge for 14h to deplete vesicles from the FBS. The 
 12 
FBS was then filter sterilized using Nalgene™ Rapid-Flow™ with 0.2 µm pores (Thery, 
Amigorena et al. 2006).  
3.2.2 Experimental Conditions 
17A and MOVAS cells were plated at 10 million cells per 10 cm dish in exome-depleted 
medium for 24 to 48h before treatment. DMEM was supplemented with exome-depleted FBS to 
a final concentration of 10% FBS exome-depleted medium for the 17A cell line and 20% FBS 
exome-depleted medium for the MOVAS cell line. High FBS concentrations were used to 
account for FBS loss during the exome depletion process.  
For the experimental conditions, the medium was then further supplemented with 10mM 
sodium phosphate buffer (NaPi), the Pi source (pH 7.4) (NaH2PO4•H2O and Na2HPO4) (as it has 
been shown that NaPi is a more controlled and direct source of Pi) or ultra-pure water. The cells 
were then grown for 24h, 48h, and 72h for vesicle collection. After 48h the medium was 
replenished. Medium and ECM derived vesicles were then collected from the 24h group and 
from the ECM only at 48h and 72h groups. In all other experiments, 5% FBS (for 17A cells) and 
10% FBS (for MOVAS cells) was used in place of exome-depleted FBS. 
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3.3 ISOLATION OF VESICLES 
3.3.1 Medium-derived matrix vesicles 
The medium MV was collected from the culture dish and centrifuged at 2,000g for 20min; the 
supernatant was then ready for further purification or stored in a 4ºC fridge for up to a week or in 
a -80ºC fridge indefinitely.  
3.3.2 Matrix-derived extracellular vesicles 
Once the medium was removed from the culture plate, the vesicles were released from the 
extracellular matrix (ECM) using enzymatic digestion. Specifically, For 17A cells DMEM was 
supplemented with 2.5 mg/ml collagenase IA (Sigma, St Louis, MO) and 2mM calcium chloride 
and added to the culture plates for 2h at 37ºC and 5% carbon dioxide for 17A cells. For MOVAS 
cells, 1 mg/ml of collagenase IA was used, and elastase (0.8U/ml) was also added to release 
matrix vesicles from MOVAS ECM. 
Each mixture was then centrifuged for 20 min at 2000g, and the supernatant was 
immediately ready for further purification or storage in a 4ºC fridge for up to a week or in an 
80ºC fridge indefinitely.  
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3.4 PURIFICATION OF VESICLES 
All vesicles were purified using several steps of ultracentrifugation. First, the Medium and ECM 
collections were centrifuged at 4ºC 10,000g for 30min to remove any cellular debris. The 
resulting supernatant was then transferred to clean tubes and centrifuged at 4ºC at 100,000g for 
1.5h to 3h. Next, the supernatant itself was discarded, and the pellet remaining after centrifuging 
was resuspended in PBS or Tris-buffered saline (TBS) (50 mM Tris–HCl, pH 7.4 and 154 mM 
NaCl) and centrifuged at 4ºC at 100,000g  for 70 min. The supernatant was again removed, and 
the remaining pellet was dissolved in PBS or TBS for further analysis and stored at -80ºC 
(Thery, Amigorena et al. 2006).  
The protein concentration of the vesicles was evaluated using a Pierce™ BCA Protein 
Assay Kit (Thermo Fisher Scientific), and its color quantification was evaluated using a 
Synergy™ H1 microplate reader (BioTek, Vermont, USA) 
3.5 QUALITATIVE AND QUANTITATIVE EVALUATION OF THE 
PREPARATION QUALITY OF EXTRACELLULAR VESICLES 
3.5.1 Cryo-electron microscopy 
Vesicles suspended in TBS were applied to holey carbon film (Quantifoil Micro Tools) and 
vitrified in liquid ethane using an FEI Vitrobot Mark IV. The grids were transferred to a Gatan 
626 cryo-sample holder and imaged in an FEI Tecnai F20 electron microscope operated at 200 
 15 
kV and nominal magnifications ranging from 32,750x to 65,500x. Low-dose images were 
captured with a Gatan Ultrascan 4000 CCD camera. 
3.5.2 Nanoparticle tracking analysis 
The size and concentration of the purified vesicles were determined by Nanoparticle Tracking 
Analysis (NTA) using NanoSight NS300 (Malvern Instruments Ltd, Worcestershire, UK). Data 
acquisition and analysis were performed using NTA 2.3 Analytical Software. One video file of 
60 seconds at camera level 10 from each sample was created. A detection threshold limit of 10 
was used to analyze the size and concentration of the vesicles. 
The percentage of the vesicles in the size range of interest was determined by adding the 
number of particles within the size range of interest and dividing by the total number of particles. 
3.5.3 Silver staining of proteins 
Samples were prepared using 1x NuPAGE™ LDS buffer and 1x NuPAGE™ Sample reducing 
agent (Thermo Fisher Scientific). They were boiled for 10 min and incubated on ice for 5 min. 
These samples were also used for the western blot analysis. The vesicle proteins (5µg) were 
separated by SDS-PAGE electrophoresis using NuPAGE™ 4-12% Bis-Tris Protein Gels 
(Thermo Fisher Scientific) at 200V for 1h.  
A Pierce™ Silver Stain Kit was used as instructed to stain the gel. A new sliver stain was 
done for each new vesicle preparation. 
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3.5.4 Western blotting 
After the vesicle samples were prepared as described in the sliver staining section, the vesicle 
proteins (7.5µg) were separated by SDS-PAGE electrophoresis using NuPAGE™ 4-12% Bis-
Tris Protein Gels and transferred onto a nitrocellulose membrane. Specific proteins were 
detected with primary antibodies against: TNAP (1:1000; R&D Systems), GLG1 (1:1000; 
Sigma), OPN (1:10000; R&D Systems), and PIAD3 (1:1000 Proteintech). Signals were detected 
using a horseradish peroxidase-conjugated secondary antibody and an enhanced 
chemiluminescence detection kit (ECL; Amersham Biosciences, Pittsburgh, PA, USA). All 
secondary antibodies (GE Healthcare or Fisher) were used at 1:3000 dilution (ani-rabbit, anti-rat, 
and anti-goat). 
3.6 DETERMINING WHETHER PHOSPHATE-INDUCED GENE 
EXPRESSION CHANGES IN 17A CELLS CORRELATE WITH AN 
ALTERATION IN MV COMPOSITION 
3.6.1 RNA isolation from total lysate of 17A cells 
Total RNA was extracted using a GenElute Mammalian Total RNA Miniprep Kit (Sigma 
Aldrich, St. Louis, MO, USA). The total RNA (1 μg), after DNase I treatment (Life 
Technologies, Grand Island, NY, USA), was converted to cDNA using a SuperScript III Reverse 
Transcriptase Kit (Life Technologies, Grand Island, NY, USA) and diluted in a ratio of 1:10 with 
ultra-pure water for further analysis. 
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3.6.2 Reverse transcription polymerase chain reaction 
Gene expression analyses were performed using a StepOnePlus™ Real-Time PCR System 
(Thermo Fisher Scientific) and Fast SYBR Green reaction mix (Roche, Indianapolis, IN, USA). 
The primer sequences were (F denotes forward primer, R denotes reverse primer): 
Akp2-F CAGTGGGAGTGAGCGCAGCC 
Akp2-R GCACTGGGTGTGGCGTGGTT 
Dmp1-F GCTGGGTCACCACCACCACC   
Dmp1-R GGAGGGTCCTCCCCACTGTCC  
Opn-F   ATGAGGCTGCAGTTCTCCTGG   
Opn-R            AAAGCTTCTTCTCCTCTGAGCTGCC 
Ank-F  CACCCTGATAGCCTACAGTGAC   
Ank-R  GGAAGGCAGCGAGATACAGG  
Phospho1-F ATGAGCGGGTGTTTTCCAGC 
Phospho1-R GGTCTTCAACACATCTTCAGC  
mPanx3-F ACCCCCATGTCTTCTGGGAT 
mPanx3-R GTAGGTGGCCACTAGCCAAT 
PTHR1-F ACTGTGGCAGATCCAGATGC 
PTHR1-R AATCTCTGCCTGCACCTCAC 
Slc13a5-F GTCGAGGGAAACACCGTTCA 
Slc13a5-R  TTGGGCGACTTTCCAATCCA 
Itga6-F  CACTCAGGTTCGAGTGACGG 
Itga6-R  CAGCCTTGTGATAGGTGGCAT 
Cdsn-F  AATGTCCAGCCCGGCATAA 
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Cdsn-R GGTCCCAATGCTCTTAGCCA   
Itga6-F  GCTGTTCTTGCCGGGATTCT 
Itga6-R  ATGCATCGGAAGTAAGCCTCT  
Sema7a-F GGGTGAGGGAGACAGGGGAGAGCGAAGA 
Sema7a-R CCTCCTTCAAAATGACCACGGCAAAT 
 
Expression was normalized to GAPDH expression, and relative expression was 
determined through comparison to the average control at the corresponding time point (ex: 48h 
control was compared to 48h Pi). 
3.6.3 Statistical analysis 
The vesicles were collected and pooled from ten 10cm dishes.  RNA was collected from 3 
controls, and 3 Pi treated 17IIA11 cells. Data are presented as the mean +/- standard deviation. 
Probability values were calculated using a Two-Tailed t-test, where p ≤ 0.05 (*), p ≤ 0.01 (**), 
and p ≤ 0.001 (***) were considered to be statistically significant. 
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4.0  RESULTS 
4.1 QUALITATIVE AND QUANTITATIVE EVALUATION OF THE 
PREPARATION QUALITY OF EXTRACELLULAR VESICLES  
4.1.1 Shape of vesicles and quality of preparation based on Cryo-EM 
4.1.1.1 Shape and quality of extracellular vesicles collected from MOVAS cells 
EV are spherical membrane-enclosed particles. For our study, we were interested in vesicles 
ranging in size from 50nm to 220nm, as this size range contains MV (Chaudhary, Kuzynski et al. 
2016, Chaudhary, Khalid et al. 2018). To evaluate the purity of the vesicles collected during the 
process described above, cryo-electron microscopy was performed on MOVAS cells.  
Vesicles were collected from MOVAS cells from either the medium or ECM and after 
elevated Pi exposure for 24h. Four groups were evaluated: Control EV-Medium, Pi EV-Medium, 
Control EV-ECM, and Pi EV-ECM. The Cryo-EM images showcased in Figure 4 demonstrate 
vesicles within the size range of approximately 50 to 120nm (indicated by white arrows). From 
the images, we can conclude that the vesicles collected using the ultracentrifugation method 
reside within the MV range of interest (50nm to 220nm) and are relatively pure, as indicated by 
the lack of significant contamination by other particles. This is especially true of the ECM 
groups, as ECM contamination by ECM collagen fibrils is absent. 
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Figure 4. Cryo-EM of extracellular vesicles (EV) released by MOVAS cells 
Cells were grown in standard conditions (Ctrl) or with 10mM phosphate (Pi). Vesicles were collected from ECM 
and medium after 24h. Scale bars are 100nm. Adapted from (Chaudhary, Khalid et al. 2018). 
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4.1.2 Verification of mass spectrometric analysis  
Further analysis of the proteins detected by mass spectrometry was done to validate the mass 
spectrometric analysis of the 17A cells, which was only performed once. To determine the 
quality of this analysis, we attempted to evaluate several proteins that were detected in MV using 
mass spectrometric analysis by using a western blot analysis on new samples. We evaluated the 
same four groups used for mass spectrometry analysis (Control MV-Medium (Crtl-med), 
Phosphate MV-Medium (Pi-med), Control MV-ECM (Ctrl-ECM), Phosphate MV-ECM (Pi-
ECM)). Of all the proteins detected, we chose proteins based on their detection from the mass 
spectrometric analysis. For example, some proteins were present in all samples, some only in the 
ECM group (ECM), some only in the medium (med) group; meanwhile, other proteins showed 
significant alterations by phosphate, both increase and decrease presence in vesicles. 
Unfortunately, of the 14 proteins tested, only 2 were detectable by western blot. This could be 
due to poor antibodies or an insufficient amount of protein present to be detectable.  
Golgi Glycoprotein 1 (Glg1) and Protein Disulfide Isomerase Family A Member 3 
(Piad3) were the two proteins detectable by western blot.  The mass spectrometric data showed a 
significant increase by elevated Pi in the ECM group, and we saw the same pattern using western 
blot analysis (Figure 5A). Silver staining of gels using the same vesicle preparation was used as a 
loading control. Of note from the silver stain is the different banding pattern in the vesicles 
collected from the medium and ECM (Figure 5B). This further confirms, after mass 
spectrometric analysis, that the MV collected from the medium and ECM are different vesicle 
populations. 
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Figure 5. Western blot analysis of proteins in MV released by 17IIA11 cells into the medium 
(med) or ECM after 24h of elevated phosphate exposure. 
A.Western blot of MV detecting Pdia3 and Glg1. 7.5ug of protein/lane. B. Silver 
stain of gel. 5ug of protein/lane. This does not seem to be correct formatting – please 
check 
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4.1.3 Size distribution analysis of ECM vesicles based on nanoparticle tracking analysis  
From the mass spectrometric analysis and the silver staining of MV proteins, we determined that 
the vesicles isolated from the ECM are significantly different from those isolated from the 
medium. Next, we focused on the ECM-derived vesicles to determine the role of phosphate in 
MV biogenesis. Vesicle biogenesis pathway effects the size of the EV released, the biogenesis 
pathway for exosomes, which are formed in the cell and released through exocytosis, results in 
vesicles that range in size from approximately 50nm to 80nm. On the other hand, apoptotic 
bodies, which are released during apoptosis, range in size from approximately 500nm to 1µm 
(Yuana, Sturk et al. 2013, Yanez-Mo, Siljander et al. 2015, Zaborowski, Balaj et al. 2015, 
Bottini, Mebarek et al. 2018). As vesicle isolation results in a heterogeneous population of 
vesicles, it is important to verify if the isolation method results in the collection of MV. If size 
distribution is altered, it may be due to a change in the biogenesis pathway. We evaluated the 
MV released from 17A cells into the ECM over 72h after exposure to 10mM Pi. This resulted in 
6 groups being used for further study: 24H Control ECM MV (24H C ECM), 24H Pi ECM MV 
(24H P ECM), 48H Control ECM MV (48H C ECM), 48H Pi ECM MV (48H P ECM), 72H 
Control ECM MV (72H C ECM), and 72H Pi ECM MV (72H P ECM).We assessed the size 
distribution of MV using nanoparticle tracking analysis to determine if Pi alters vesicle size 
distribution. 
4.1.3.1 Evaluating extracellular vesicle preparation using nanoparticle tracking analysis 
The vesicle size range of interest to this study is between 50nm to 220nm, which includes 
exosomes (50nm to 79nm in size) and matrix vesicles (80 nm to 220 nm in size). For the purpose 
of our study, we strictly classified the vesicles collected based on size; it should be noted that 
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these are the approximate size ranges of exosomes and MV respectively. Particles smaller than 
50nm are most likely small protein aggregates or small pieces of cellular debris. Larger particles 
may be protein clumps, large pieces of cellular debris that weren’t removed, or apoptotic 
vesicles.  
Our vesicle preparations were between 73% and 88% vesicles of interest (Table 1.) This 
is similar to preparations done in our lab previously (Chaudhary, Kuzynski et al. 2016). 
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Table 1. Nanoparticle Tracking Analysis of MV released from 17IIA11 cells 
Sample Mean  
Sample 
Size 
Mode 
Sample 
Size 
Percent of 
Sample Sized 
between 50 and 
80nm 
(Exosomes) 
Percent of 
Sample 
Sized 
Between 80 
and 220nm 
(Matrix 
Vesicles) 
Total 
Preparation in 
Range of 
Interest 
(50nm to 
220nm) 
24 H C 
ECM 
96nm 59nm 28% 47% 75% 
24H P 
ECM 
97nm 75nm 25% 53% 78% 
48H C 
ECM 
129nm 104nm 18% 70% 88% 
48H P 
ECM 
121nm 71nm 24% 59% 83% 
72H C 
ECM 
127nm 70nm 18% 55% 73% 
72H P 
ECM 
145nm 89nm 16% 64% 80% 
 
 
 
 26 
 
 
 
 
 
 
 
 
Figure 6. Size distribution of EV collected from 17IIA11 cells. 
Cells were grown under standard growth conditions (Ctrl) or with 10 mM Pi (Pi). EVs were isolated from 
the extracellular matrix (ECM) after 24, 48, and 72h. Vesicle preparations were evaluated using 
nanoparticle tracking analysis. The graphs demonstrate the size distribution of particles contained within 
the samples. Again – check to see how much info should be here under the figure. 
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4.1.3.2 Comparing extracellular vesicles released from 17ⅡA11 cells grown in elevated 
Phosphate Conditions 
Although Pi exposure has been shown to alter the composition of MV, the mechanism through 
which this alteration occurs is unknown. One-way Pi may alter vesicle composition is through 
alteration of vesicle biogenesis. We used nanoparticle tracking analysis to determine if the size 
of the vesicles changed in response to elevated Pi. Using the nanoparticle tracking data, we 
evaluated the size distribution of MV between treated and non-treated groups at the same time 
point.  
We did not identify differences in size distribution between the control and Pi groups at 
each time point. Comparing the mean particle size of control at and Pi groups at 24h, we found 
that it was 96 and 97nm, respectively. The mean particle size of control at 48h and Pi at 48h was 
129 and 121nm, respectively. A larger difference in mean particle size was observed between the 
control at 72h and Pi at 72h groups, 127 and 145nm, respectively, however, this difference is due 
to increased contamination by particles larger than 220nm, not due to an increase in average 
vesicle size (Table 1 and Figure 6) .  
4.1.3.3 Comparing extracellular vesicles released from 17ⅡA11 cells grown in elevated 
phosphate conditions over time 
To determine if MV size changed over time in response to elevated Pi, we used the nanoparticle 
tracking data to analyze the size distribution of vesicles released by 17A cells over time, from 
24h of elevated Pi exposure to 72h of elevated Pi exposure. We did not identify differences in 
size distribution within the vesicle groups collected from the ECM over time.  
In the 24h Pi group, the mean particle size was 97nm, and the mode size of the particles detected 
was 75. After 48h the mean particle size increased to 121nm, but the mode particle size was only 
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71nm. Further, after 72h, the mean particle size increased to 145nm, but the mode particle size 
only increased to 89. These changes are in the lower range of MV size and are not meaningfully 
different. However, as this experiment was only performed once, statistical significance could 
not be ascertained. (Table 1 and Figure 6). The increasing mean identified here can be explained 
by an increase in the number of contaminating particles over 220nm the longer treatment 
continues. The mode particle size of each sample is the size of particle most commonly detected. 
This does not shift meaningfully as the experiment progresses. This indicates that the pathway 
producing the vesicles is still the same, even though the mean is increasing. 
4.2 DETERMINING WHETHER PHOSPHATE-INDUCED GENE 
EXPRESSION CHANGES IN 17A CELLS CORRELATE TO AN 
ALTERATION IN MV COMPOSITION 
In an unpublished RNA-seq analysis, we determined that elevated Pi alters the gene expression 
of 17A cells. Many of the genes affected are known to be involved in the mineralization of the 
ECM (TNAP, Dmp1, and Opn). Pi also induces the release of MV, the nucleation sites of 
hydroxyapatite(Chaudhary, Kuzynski et al. 2016).As we have shown that exposure to elevated Pi 
alters the composition of MV, we wanted to determine if some of the alterations in MV 
composition we identified were due to the alteration of gene expression. 
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Genes were chosen for examination based on at least one of four criteria (genes selected 
based on the criteria stated are listed in ()): alteration in expression in response to Pi as indicated 
by RNA-seq analyses (all genes selected for analysis),presence in MV as indicated by our mass 
spectrometry analysis (Dmp1, Opn, Itag6, Akp2, Pth1r, Panx3, Slc13a5, Cdsn), presence in EV 
based on the literature (Itga6, Sema7a, TNAP, Panx3, and Slc13a5 (Thouverey, Malinowska et 
al. 2011)), or function (all genes selected for analysis). 
 
4.2.1 Determination if Pi induced MV composition change is related to Pi-induced gene 
expression changes (increased expression). 
Osteopontin (Opn) is a non-collagenous protein present in the extracellular matrix (ECM) of 
mineralized tissue (McKee and Nanci 1996). Elevated Pi significantly increases the expression 
of Opn in 17A cells after 24h (p ≤ 0.001), and increased expression was continued for 72h (p ≤ 
0.05) (Figure 7). A small number of particles of Opn were detected in the medium and the ECM 
vesicles after exposure to Pi by mass spectrometry analysis, but this was not replicated in the 
western blot analysis (Figure 8, and Table 2). The detected levels of Opn in the mass 
spectrometry analysis were at low levels, which may not have been sufficient for detection by 
western blot. There was also a significant amount of background, which may have obscured the 
signal. 
Progressive ankylosis protein (Ank) is a transmembrane protein that transports inorganic 
pyrophosphate from the intercellular space into the ECM. Loss of this protein in mice has been 
shown to decreased bone mass (Kim, Minashima et al. 2010, Wuthier and Lipscomb 2011). In 
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our study, Ank showed a significant increase in gene expression at 24h (p ≤ 0.001) and 48h (p ≤ 
0.05) after Pi exposure (Figure 7). Ank was not detected in the matrix vesicles (Table 2). 
Dentin matrix phosphoprotein 1 (Dmp1) is another protein that localizes to the ECM; it is 
responsible for nucleating hydroxyapatite (Wu, Teng et al. 2011). Elevated Pi significantly 
increased expression of Dmp1 in 17A cells after 24h (p ≤ 0.001), and this increased expression 
was maintained for 72h (p ≤ 0.05) (Figure 7). A small number of particles of Dmp1 were 
detected in medium vesicles after exposure to Pi (Table 2). 
Integrin alpha 6 (Itga6) is a cell-surface adhesion receptor that binds to the ECM and 
mediates cell–ECM interactions (Wang, Choi et al. 2014, Yanez-Mo, Siljander et al. 2015). 
Elevated Pi significantly increased the expression of Itga6 in the 17A cells after 24h (p ≤ 0.001), 
and the increased expression was maintained for 48h (p ≤ 0.05) (Figure 7). It was detected in the 
vesicle groups: Cntrl-Medium EV, Pi –Medium EV, and Pi –ECM MV, but there was no 
significant alteration by Pi (Table 2). 
Semaphorin 7A (Sema7a) is a GPI-anchored membrane glycoprotein, and mutations of 
this gene have been implicated in reduced bone mineral density (Delorme, Saltel et al. 2005). 
Sema7a was not detected in matrix vesicles, even though it showed a significant increase in 
expression after 24h (p ≤ 0.01) and maintained the significant increase in expression at 72h (p ≤ 
0.05) (Figure 7 and Table 2). 
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Dual Specificity Phosphatase 6 (Dusp6) is a cytosolic MAP kinase phosphatase that 
specifically recognizes and inactivates the ERK1/2, a known mediator of Pi signaling. In a 
previous study, a Dusp6 mutant mouse showed dwarfism and coronal craniosynostosis 
(Bradshaw and Dennis 2010). Dusp6 was not detected in the matrix vesicles, even though it 
showed a significant increase in expression after 24h (p ≤ 0.01) and maintained increased 
expression for 48h (p ≤ 0.05) (Figure 7 and Table 2). 
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Figure 7. Analysis of upregulated genes in 17A cells after exposure to elevated Pi   
RNA from 17IIA11 cells were collected under standard growth conditions (Control) at 24h, 48h, 72h 
and upon 24h,48h, and 72h after treatment with 10 mM Pi (Pi).  Fold change for the phosphate treated 
groups was determined relative to control, which was set at 1. p ≤ 0.05 (*), p ≤ 0.01 (**), and p ≤ 0.001 
(***).p ≤ 0.05 (*), p ≤ 0.01 (**), and p ≤ 0.001 (***). 
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Table 2. Detection pattern in MV of genes upregulated by Pi using mass spectrometry 
Gene Detection of Protein in MV after 24h Pi exposure 
(17A) 
Dmp1 Pi –Medium EV 
Ank No detection 
Opn Pi –Medium EV 
Pi –ECM MV 
Itag6 Cntrl-Medium EV 
Pi –Medium EV 
Pi –ECM MV 
No significant alteration by Pi 
Sema7a No detection 
Dusp6 No detection 
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Figure 8. Western blot analysis of proteins in MV released into the ECM from 
17IIA11 cells after 72h of elevated Pi exposure. 
A. Western blot analysis of Opn and Akp2/TNAP. MV loaded at 7.5ug/lane and total cell 
lysate at 10ug protien/lane. B. Silver stained gel of MV from the same preparation as 
those prepared for western blot 5ug protein/lane were loaded.  
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4.2.2 Determination if Pi induced MV composition change is related to Pi-induced gene 
expression changes (decreased expression). 
Tissue non-specific alkaline phosphatase (Akp2/TNAP) is a membrane protein that converts 
pyrophosphate to Pi. Mutations in AKP2 lead to a condition called hypophosphatasia, where bone 
mineralization is severely impaired (Ciancaglini, Yadav et al. 2010, Wuthier and Lipscomb 
2011, Huesa, Houston et al. 2015). At 24h, 48h and 72h of elevated Pi exposure, Akp2 showed a 
significant decrease in expression using qRT-PCR (p ≤ 0.05, p ≤ 0.01, and p ≤ 0.05, respectively) 
(Figure 9). Akp2 was detected in all vesicle groups, but no significant change in Akp2/TNAP 
was detected by mass spectrometry or western blot (Figure 8 and Table 3). 
Phosphoethanolamine/Phosphocholine Phosphatase (Phospho1) is a member of the 
haloacid dehalogenase superfamily. It is involved in MV-mediated mineralization. It plays a role 
in savaging Pi within the MV lumen to promote hydroxyapatite formation. Phospho-/- mice have 
shown decreased mineral density among other skeletal abnormalities (Roberts, Stewart et al. 
2004, Ciancaglini, Yadav et al. 2010, Huesa, Houston et al. 2015). Over 24h and 48h, Phospho1 
showed a significant decrease in expression using qRT-PCR (p ≤ 0.05, and p ≤ 0.01, 
respectively) (Figure 9). It was not detected in MV (Table 3). This shows that it was never 
trafficked into the MV and, therefore, its decreased expression does not affect MV composition. 
Parathyroid hormone 1 receptor (Pth1r) is the receptor for the parathyroid hormone. It is 
a transmembrane protein that is part of the regulatory pathway that maintains phosphate and 
calcium homeostasis. Several human diseases with bone and dental phenotypes are associated 
with mutations in PTH1R, such as Blomstrand’s lethal chondroplasia, and Familial primary 
failure of tooth eruption (Cheloha, Gellman et al. 2015, Fan, Bi et al. 2016). Pth1r showed a 
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significant decrease in expression after 24h (p ≤ 0.01) and 48h (p ≤ 0.05) (Figure 9). It was only 
detected in the control vesicles at a low level (Table 3). 
Pannexin 3 (Panx3) is a protein involved in cell-cell and cell-matrix communication. 
Mice lacking Panx3 have shown delayed and disorganized mineral deposition (Oh, Shin et al. 
2015, Ishikawa and Yamada 2017). After 24h of Pi exposure, Panx3 showed a significant 
decrease in expression (p≤ 0.001) as well as at 48h (p ≤ 0.05) and 72h (p ≤ 0.01) using qRT-PCR 
(Figure 9). It was present in all 17A released extracellular vesicles (EV) and showed no 
significant alteration by Pi (Table 3). 
Solute Carrier Family 13 Member 5 (Slc13a5) is a sodium-dependent citrate transporter. 
Up to 70% of citrate is stored in bone, and citrate helps stabilize and nucleate hydroxyapatite 
crystals. Slc13a5-/- C57BL/6 mice have shown decreased bone mineral density and impaired 
bone formation, along with impaired enamel formation (Irizarry, Yan et al. 2017). Slc13a5 
showed a significant decrease in expression over 24h (p ≤ 0.01) and 48h (p ≤ 0.01) using qRT-
PCR (Figure 9). Slc13a was present at a low level in the control vesicle groups but not in the 
vesicles treated with Pi (Table 3). 
Corneodesmosin (Cdsn) is an extracellular matrix/cell adhesion molecule (Xiao, 
Camalier et al. 2007). After 24h of Pi exposure, it showed a significant decrease in expression (p 
≤ 0.05) as well as at 48h (p ≤ 0.01) and 72h (p ≤ 0.05) using qRT-PCR (Figure 9).   In the mass 
spectrometry analysis, it was only detected in the Pi-MV group, but at low levels (Table 3). This 
finding is contrary to the gene expression analysis, indicating that the decrease in Cdsn mRNA 
does not affect its trafficking into the MV. 
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In summary, when gene expression changes are compared to MV composition, the 
changes do not appear to correlate to MV composition after 24h of Pi exposure. Furthermore, 
analysis by western blot of Opn and TNAP in MV does not show a correlation to gene 
expression.  
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Figure 9 Analysis of downregulated genes in 17A cells after exposure to elevated Pi   
RNA from 17IIA11 cells were collected under standard growth conditions (Control) at 24h, 48h, 72h and 
at 24h,48h, and 72h after treatment with 10 mM Pi (Pi).Fold change for the phosphate treated groups was 
determined relative to control, which was set at 1 p ≤ 0.05 (*), p ≤ 0.01 (**), and p ≤ 0.001 (***). 
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Table 3. Detection Pattern in MV of Genes Downregulated by Pi Using Mass Spectrometry  
Gene Detection in EV after 24h Pi exposure 
(17A) 
Akp2 Present in all samples. 
No significant alteration by Pi 
Phospho1 No detection 
Pth1r Cntrl –Medium EV 
Cntrl–ECM MV 
Panx3 Present in all samples. 
No significant alteration by Pi 
Slc13a5 Cntrl –Medium EV 
Cntrl–ECM MV 
Cdsn Pi –ECM MV 
 40 
5.0  DISCUSSION 
Recently, our lab has established that exposure to elevated Pi induces the release of matrix 
vesicles (MV) from both pre-odontoblast and vascular smooth muscle cells (Chaudhary, 
Kuzynski et al. 2016, Chaudhary, Khalid et al. 2018). Using mass spectrometric analysis, we 
determined that exposure to elevated Pi alters the composition of these vesicles (Figure 2) 
(Chaudhary, Khalid et al. 2018). In an unpublished RNA-seq analysis evaluating the effect of Pi 
on pre-odontoblast cells, we identified gene expression changes of many proteins involved in 
mineralization. The purpose of the present study was to determine if gene expression changes 
induced by elevated Pi contributed to alteration of MV composition. 
While not the focus of the present investigation, we determined that Pi did not alter the 
size distribution of MV released from 17A cells.  As size distributions are indications of vesicle 
type and therefore biogenesis pathway, this finding suggests that vesicles are generated through 
the same pathway even though their composition, and presumably function, are altered. 
 This study is the first to evaluate the relationship between gene expression and MV 
composition. We demonstrated significant changes in gene expression when 17A cells were 
exposed to elevated Pi over 72h. However, this did not appear to correlate with changes in the 
protein composition of the MVs (Figure 7, 8, 9, Table 2 and 3). This suggests that phosphate 
signaling, especially at the 24h time point, regulates protein processing and/or trafficking, which 
will direct relevant proteins into MV, separate from its action on gene expression. 
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However, this does not mean that gene expression changes do not contribute to the 
alteration of vesicle composition at later timepoints.  Another possibility for why gene 
expression and alteration of protein composition do not show a correlation is that the timeframe 
used in this study to evaluate protein alteration may have been too short to determine the effects 
of gene expression changes. A longer, more comprehensive evaluation of MV composition and 
transcriptome analysis would need to be performed to determine if gene expression changes alter 
MV composition after longer exposure to elevated Pi.  
Gene expression may also alter the composition of vesicles through alteration of the RNA 
composition of MV. EV are known to contain different types of RNA, including mRNA 
(György, Szabó et al. 2011, Yuana, Sturk et al. 2013, Zaborowski, Balaj et al. 2015, Rilla, 
Mustonen et al. 2017). Analysis of the proteins altered by Pi in MV released from pre-
odontoblasts and vascular smooth muscles cells identified proteins involved in RNA processing 
overrepresented in proteins increased by Pi in MV (Figure 10). The alteration of these RNA 
processing proteins by Pi in MV may also indicate a change in MV nucleic acid composition. A 
way to evaluate this possibility would be to evaluate the nucleic acid composition of MV and 
compare that to total cell gene expression.  
The MV samples used to evaluate changes in vesicle composition were most likely a 
heterogeneous EV population. In order to determine the purity of our samples, we implemented 
several quality control experiments: Cryo-EM, silver stain, and nanoparticle tracking analysis. 
We have determined that this collection mostly contains MV because of the size distribution 
profile and enrichment of TNAP (a protein enriched in MV). However, the collection most likely 
contains a small population of other types of EV as well. Most published evaluations of EV 
employ differential centrifugation to concentrate and partially purify vesicles. Generally, the 
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centrifugation steps include depletion of cellular debris then isolation of vesicles using greater 
than 100,000g speeds. The centrifugation speed can be calibrated to collect EV within a size 
range of interest. Using this method, we collected vesicles between 50nm and 220nm, and we 
confirmed our collection method by evaluating MV samples collected from MOVAS cells using 
Cryo-EM. However, these samples are still heterogeneous in nature (Thery, Amigorena et al. 
2006). 
Another method of EV isolation is size-exclusion chromatography. In this method, the 
EV are isolated based on size through a filter column. However, this method requires a pre-
concentration step that may result in deformed EV or their rupture. This method will also result 
in different types of EV being present in the sample if they are in the same size range (Szatanek, 
Baran et al. 2015). Due to the heterogeneous nature of the sample preparation, there is a 
possibility that subtypes of MV are responsible for distinct functions: some to form 
hydroxyapatite, some to alter the ECM, and others to facilitate cell-cell communication (Witwer, 
Buzás et al. 2013). New techniques will need to be developed to better isolate and evaluate MV 
to determine more about their biogenesis and range of functions. 
In this study, we evaluated the protein MV released from pre-odontoblastic cells. Other 
studies, however, have evaluated MV protein composition using osteoblasts or chondrocytes in 
vitro and cartilage tissue from an in vivo model. One group, for example, collected MV from 
femurs of chicken embryos, and while they identified many of the same proteins found in mouse 
osteoblast and chondrocyte MVs, they had different amounts present, indicating that it is 
important to consider the source when evaluating composition (Balcerzak, Malinowska et al. 
2008).  
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Other studies have focused only on the composition of MV released from differentiating 
precursor cells without evaluating how the composition of MV may change. Our previous studies 
have shown that elevated Pi exposure not only stimulates MV release, but it also alters the 
composition of those MV. One group obtained MV from differentiating MC3T3‐E1 cells and 
evaluated vesicles from both the ECM and the medium after 15 days of osteogenic 
differentiation. They identified many proteins involved in mineralization, such as TNAP. 
However, they did not fully address if there were differences between the medium and ECM 
groups.Instead, they assumed that the vesicles collected from both were the same (Xiao, 
Camalier et al. 2007) . The novelty of our previous studies in comparison to both these proteomic 
approaches is that we attempted to, and did, identify a MV release initiator (Pi). Using proteomic 
analysis, we were able to determine that vesicles released into the medium and ECM are 
different vesicles populations. Finally, we determined that Pi alters the composition of MV. 
These findings led us to wonder how Pi alters the composition of vesicles (Chaudhary, Kuzynski 
et al. 2016, Chaudhary, Khalid et al. 2018). 
 This present study is the first to evaluate a possible mechanism driving changes in MV 
composition released from osteogenic cells undergoing mineralization. By understanding the 
mechanism behind altered vesicle composition, we may be able to harness this understanding to 
develop new drug delivery or drug packaging methods. Future studies should employ a 
comprehensive and long-term evaluation of MV composition in comparison to gene expression 
to further elucidate a possible mechanism driving composition change and modulation of MV 
cargo. 
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Figure 10. Protein profiling of EV released from 17IIA11 cells and altered by elevated 
phosphate. 
EV released from 17IIA11 cells were collected under standard growth conditions (Ctrl) and upon 24h 
treatment with 10 mM Pi (Pi) both from conditioned medium (Med) and from the extracellular matrix (ECM).  
Bar chart of difference presenting the statistical overrepresentation test analysis results of proteins 
significantly changed by Pi (> 3-fold difference) and proteins present only in either Ctrl or in Pi group in 
annotation datasets of PANTHER GO-Slim for Biological process and molecular functions. All 1164 proteins 
identified by mass spectrometry were used as a reference. Statistically significant (p<0.05) results are shown. 
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6.0  CONCLUSIONS 
In conclusion, this study demonstrated that while vesicle composition is altered due to Pi, MV 
size distribution is not altered. This indicates that the biogenesis pathway producing MV is 
unaltered by Pi, but the composition of the vesicles is affected. We attempted, for the first time, 
to determine a possible mechanism driving composition change in MV by Pi. From these studies, 
we have determined that gene expression changes are not responsible for changes in MV 
composition in the time frame evaluated (24h). This indicates that Pi signaling most likely 
influences trafficking and/or packaging of proteins separate from its influence on gene 
expression. 
However, this does not mean that RNA expression changes do not alter the composition 
of vesicles. First, the transcriptome of MV may be altered or a longer evaluation period may be 
needed to determine if vesicle composition correlates to gene expression changes. Further studies 
evaluating MV composition over time will be required to investigate these possibilities.  
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